Friday, May 27, 2022

TAG

Bharat Biotech

The Wire asked to take down 14 articles against Covaxin by Court

The Leftist propaganda news portal The Wire has been asked to take down 14 of its articles against the Indian pharmaceutical companyBharat Biotech and...

Bharat Biotech shames the media houses by name who ran down Covaxin

After various media reports surfaced, questioning the efficacy and implications of Covaxin, Bharat Biotech took to its Twitter handle and explicitly named media portals...

Covaxin maker laments “fake news”, has hit our morale

Ahead of the World Health Organisation’s technical advisory group meet to consider emergency use listing of India’s indigenous Covid vaccine Covaxin, Bharat Biotech founder...

Call on Covaxin by WHO on October 26: Swaminathan

World Health Organisation chief scientist Soumya Swaminathan has informed that the technical advisory group examining the vaccine would meet on October 26 to consider...

Decision on Covaxin approval no later than October, says WHO

The World Health Organization has declared that it would decide on the inclusion of Covaxin in its Emergency Use Listing no later than October.  The...

Covaxin gets approval from Hungary; Bharat Biotech says only the Ist step

In a big boost, Bharat Biotech's Covid-19 vaccine Covaxin has received Good Manufacturing Practices (GMP) compliance certificate from Hungary. Bharat Biotech took to Twitter to...

Covaxin looks good, says WHO’s chief scientist: Decision on use likely by August

As Bharat Biotech’s Covid-19 vaccine, Covaxin awaits World Health Organisation’s (WHO) approval, its’ chief scientist Dr. Soumya Swaminathan said the Phase-3 trial data of...

Covaxin over Pfizer by Brazil and its enemies are are working up a storm

Brazil’s health ministry, in February, signed an agreement to purchase 20 million doses of the Covaxin vaccine manufactured by India’s Bharat Biotech. The agreement drew...

Boost for Covaxin’s pending approval: Bharat Biotech to meet WHO today

Bharat Biotech, manufacturer of India's homegrown vaccine against Covid-19 Covaxin, would attend a pre-submission meeting with the World Health Organization (WHO) today.  Earlier on June...

Covaxin has 77.3% efficacy: Phase 3 trials data

Bharat Biotech have announced that the indigenously developed Covid-19 vaccine Covaxin has showed a 77.3 per cent efficacy in its phase 3 trials. The company...

Voices

174 POSTS0 COMMENTS
150 POSTS0 COMMENTS
Support Us
Contribute to see NewsBred grow. And rejoice that your input has made it possible.